Cite
Towards a Maraviroc long-acting injectable nanoformulation
MLA
Andrew Owen, et al. Towards a Maraviroc Long-Acting Injectable Nanoformulation. May 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c7a6f1e631de49ae4ea532590204b701&authtype=sso&custid=ns315887.
APA
Andrew Owen, Lee Tatham, Trevor Scott, Steven Paul Rannard, Marco Siccardi, A. B. Dwyer, Andrew Clark, Alison C. Savage, & Manoli Vourvahis. (2019). Towards a Maraviroc long-acting injectable nanoformulation.
Chicago
Andrew Owen, Lee Tatham, Trevor Scott, Steven Paul Rannard, Marco Siccardi, A. B. Dwyer, Andrew Clark, Alison C. Savage, and Manoli Vourvahis. 2019. “Towards a Maraviroc Long-Acting Injectable Nanoformulation,” May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c7a6f1e631de49ae4ea532590204b701&authtype=sso&custid=ns315887.